PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
June 17, 2026Journal of Cosmetic and Laser Therapy0 citationsOpen Access

Radiofrequency microneedling for skin rejuvenation of the periorbital region – a prospective, clinical study

View Full Paper
LNLynhda NguyenCDCathy DierickxsensSSStefan W. Schneider

Key Points

  • This study aims to evaluate the effectiveness and safety of radiofrequency microneedling (RFMN) for treating periorbital wrinkles and fine lines.
  • Prospective, evaluator-blinded clinical study.
  • Patients underwent 1-3 RFMN sessions at 6-8-week intervals, with follow-up 6 months post-treatment.
  • Outcomes assessed using automated imaging software and a 5-point rating scale by two blinded dermatologists.
  • Mean wrinkle reduction of 25.3% in the infraorbital area and 37.3% in the crow's feet region (±40.4% and ±64.0% respectively).
  • Blinded evaluators reported a mean clinical score of 3.21 ± 0.98, indicating variable improvement.
  • Transient erythema and edema were common but resolved within days, with no severe adverse events.

Abstract

Minimally invasive treatments such as fractional lasers are well-established options for addressing the aging skin in the periorbital region. Among energy-based devices, radiofrequency microneedling (RFMN) has emerged as a potential alternative. To evaluate the effectiveness and safety of RFMN for periorbital rejuvenation. In this prospective, evaluator-blinded clinical study, patients with periorbital wrinkles and fine lines received 1-3 RFMN sessions at 6-8-week intervals. Follow-up occurred 6 months after the final treatment. Outcomes were assessed using automated imaging software and a 5-point numeric rating scale (1 = very much improved; 5 = worsened) by two blinded, board-certified dermatologists. Adverse events (AEs) were documented. In total, 25 patients were included. Imaging analysis showed mean wrinkle reduction of 25.3 ± 40.4% in the infraorbital area and 37.3 ± 64.0% in the crow's feet region. Blinded evaluators reported a mean clinical score of 3.21 ± 0.98, reflecting variable improvement. All patients experienced transient erythema and edema, resolving within days. No severe AEs occurred. RFMN appears to be a promising option for periorbital rejuvenation with minimal downtime. Larger comparative studies are needed to confirm efficacy and define its role relative to established treatments.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Nguyen et al. (2026) studied this question.

synapsesocial.com/papers/6a3238e2d50b63ecad2049e2https://doi.org/10.1080/14764172.2026.2680304
Ask AI
Helpful
Bookmark
Share
View Full Paper